US Patent 12133915 Method of treating epilepsy

Is a

Patent

Patent attributes

Patent Applicant

Alexza Pharmaceuticals

Current Assignee

Alexza Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121339150

Patent Inventor Names

Lily Gong0

James Cassella0

Edwin S. Kamemoto0

Date of Patent

November 5, 2024

Patent Application Number

177211830

Date Filed

April 14, 2022

Patent Citations

‌

US Patent 7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route

‌

US Patent 7008615 Delivery of anti-migraine compounds through an inhalation route

‌

US Patent 7008616 Delivery of stimulants through an inhalation route

‌

US Patent 7011819 Delivery of rizatriptan or zolmitriptan through an inhalation route

‌

US Patent 7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route

‌

US Patent 7014840 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route

‌

US Patent 7014841 Delivery of antiemetics through an inhalation route

‌

US Patent 7018619 Delivery of alprazolam, estazolam midazolam or triazolam through an inhalation route

...

Patent Primary Examiner

CPC Code

Patent abstract

Alprazolam formulated as an inhaled condensation aerosol and method for treating epilepsy and/or seizures.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12133915 Method of treating epilepsy

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12133915 Method of treating epilepsy